Evidence map›Paper›PMID 26819052›Full record

ArticleHaematologica2016

Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.

Nicolas Guillaume, Pascale Loiseau, Katia Gagne, Hélène Moins Teissserenc, Jean-Michel Cayuela, Guylaine Henry, Marie Robin, Régis Peffault de Latour, Eliane Gluckman, Gérard Socié and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. [Unlicensed natural killer cells and allogeneic hematopoietic stem cell transplantation].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nicolas GuillaumeUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Amiens, France Laboratoire d'Hématologie et d' Histocompatibilité, EA 4666 «Lymphocyte Normal - Pathologique et Cancers», Centre Hospitalier Universitaire, Amiens, France.
Pascale LoiseauUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Amiens, France Assistance Publique-Hopitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie et Histocompatibilité, Paris, France Inserm, UMRS-1160, Institut Universitaire d'Hématologie, Paris.
Katia GagneEtablissement Français du Sang (EFS), Laboratoire d'Histocompatibilité, Nantes, France EFS, Laboratoire de Recherche EA4271, Nantes, France LabEx Transplantex, University of Strasbourg, Paris, France.
Hélène Moins TeissserencUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Amiens, France Assistance Publique-Hopitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie et Histocompatibilité, Paris, France Inserm, UMRS-1160, Institut Universitaire d'Hématologie, Paris Université Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, EA3518, Paris, France.
Jean-Michel CayuelaUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, EA3518, Paris, France AP-HP, Laboratoire d'Hématologie, Hôpital Saint-Louis, Paris, France.
Guylaine HenryAssistance Publique-Hopitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie et Histocompatibilité, Paris, France.
Marie RobinAP-HP, Hématologie -Transplantation; Hôpital Saint Louis, Paris, France.
Régis Peffault de LatourAP-HP, Hématologie -Transplantation; Hôpital Saint Louis, Paris, France.
Eliane GluckmanEurocord, Hopital Saint-Louis, Paris, France.
Gérard SociéUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Amiens, France AP-HP, Hématologie -Transplantation; Hôpital Saint Louis, Paris, France.
Christelle RetiereEFS, Laboratoire de Recherche EA4271, Nantes, France LabEx Transplantex, University of Strasbourg, Paris, France.
Nicolas DulphyUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Amiens, France Assistance Publique-Hopitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie et Histocompatibilité, Paris, France Inserm, UMRS-1160, Institut Universitaire d'Hématologie, Paris LabEx Transplantex, University of Strasbourg, Paris, France nicolas.dulphy@univ-paris-diderot.fr.
Antoine ToubertUniversité Paris-Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Amiens, France Assistance Publique-Hopitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie et Histocompatibilité, Paris, France Inserm, UMRS-1160, Institut Universitaire d'Hématologie, Paris LabEx Transplantex, University of Strasbourg, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cord Blood Stem Cell TransplantationAdultAllograftsFemaleHematologic DiseasesHLA-C AntigensHumansKiller Cells, NaturalMaleHLA-C Antigenscord blood transplantationimmunogeneticsnatural killer cells

Identifiers

PMID26819052
PMCPMC5004361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.